EVOlve your treatment with extracellular vesicles derived from plants.
We use extracellular vesicles from plants and fruits to create new technology platforms for wound care therapy and drug delivery.
Submission Acknowledgement Receipt
PROF. GIOVANNI CAMUSSI PRESENTS EVOBIOTECH’S WORK, WATCH THE TALK!
Submission Acknowledgement Receipt
PROF. GIOVANNI CAMUSSI PRESENTS EVOBIOTECH’S WORK, WATCH THE TALK!
On May 1-2, 2023 took place the ERCC19, the 19th Investigators’ Meeting of the Extracellular RNA Communication Consortium (ERCC).
The ERCC is an NIH Common Fund program launched in 2013 to study extracellular RNA (exRNA). The first phase of the project focused on exRNA biology and its potential use in the diagnosis and treatment of a variety of diseases. A second phase initiated in 2019 sought to develop new and improved technologies to identify, characterize, and isolate exRNA and carriers, such as extracellular vesicles and RNA binding proteins (RBPs).
Professor Giovanni Camussi is a member of ERCC consortium. He was invited to talk at the latest edition, ERCC19, describing the recent discoveries of EvoBiotech.
You can watch the complete talk in the following video.
Latest news
PUBLICATION
11th July 2023
Turin
EvoBiotech published its last results on the use of extracellular vesicles derived from plants as a drug delivery system in the special issue “Extracellular Vesicles and Nucleic Acids in Health and Disease” of Cells Journal. This work demonstrates the use of edible plant-derived extracellular vesicles to vehicle mRNA-based vaccines for SARS-CoV-2 using an easy-to-use formulation […]
PRESS
2nd June 2023
Italy
EU Startup.news is a popular website covering news about the European startup landscape and pointing-out the most promising startups for investment opportunities. We are pleased to share that EvoBiotech has been cited as one of the 15 innovative Italian Startups that are revolutionizing biotechnology in Italy. According to EU Startup.news, EvoBiotech is a cutting-edge biotech […]
CONGRESSES
24th May 2023
Seattle (WA)
EvoBiotech participated to the Annual Meeting of International Society for Extracellular Vesicles (International ISEV 2023) in Seattle to present its last results on the innovative use of plant extracellular vesicles as a delivery platform for mRNA-based vaccines.